Spider-Man: Brand New Day siRNA science earns its first expert review, as Cambridge biochemist Soren Hough confirms the film ...

Renaissance BioScience, a leader in yeast bioengineering providing solutions, has announced a new Genome BC funded project to extend the reach of its yeast-based RNA interference (RNAi) biopesticide ...

A plot device in the new Spider-Man movie is real-world science. A trick used to turn off fictional superpowers in the movie is based on actual genetic therapies for rare diseases.

ST Pharm announced on August 18 that it will hold the international symposium "RISC 2026" for RNA (ribonucleic acid) ...

Built from short, synthetic strands of DNA or RNA, oligonucleotides offer a fundamentally different way to influence disease ...

Just two weeks later, AI biologics company Chai Discovery unveiled a licensing agreement with Pfizer that provides the ...

Gene therapy ethics became a live institutional dispute in April 2026, when the FDA approved Otarmeni for inherited deafness ...

(NASDAQ: ARWR) today announced that people in Germany who live with a rare metabolic condition called Familial Chylomicronaemia Syndrome (FCS) are the among first in the European Union to have a new ...

REDEMPLO (plozasiran) is listed in the Lauer-Taxe database as an adjunct to diet to reduce triglyceride levels in adult patients with familial chylomicronaemia syndrome (FCS), diagnosed either based ...

WA Native Ward Ships Touchy West for Longacres Mile. In four decades as a jockey and trainer, Wesley Ward has won just about everything in racing except the Longacres Mile. That c ...

RNA drug development is accelerating as therapies expand beyond the liver, with Novartis, Arrowhead and Korean firms OliX, ...

Successfully transitioned SIL204 from regulatory preparation into an active Phase 2/3 clinical program in locally advanced pancreatic cancer, ...